Yoga May Aid Heart Failure Outcomes When Added to Optimal Medical Therapy
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
MONDAY, Oct. 2, 2023 -- Yoga therapy may improve physical well-being and left ventricular function among heart failure patients on guideline-directed optimal medical therapy, according to a study presented at the American College of Cardiology Asia 2023 conference, held from Sept. 29 to 30 in Manila, Philippines.
Ajit Singh, Ph.D., from Kasturba Medical College and Hospital in Manipal, India, and colleagues assessed the long-term impact of yoga on heart failure outcomes compared to standard care. The analysis included 75 heart failure patients (New York Heart Association class III or less) who underwent coronary intervention, revascularization, or device therapy within the past six months to one year while continuing guideline-directed optimal medical therapy.
The researchers observed no significant differences between the yoga and standard care group with respect to echocardiographic parameters. However, in both groups, the echocardiographic parameters significantly improved from baseline to six months and one year. Yoga was associated with substantial improvement in functional outcome (New York Heart Association classes) at follow-up.
"This study proves that the addition of yoga therapy to standard medical management of heart failure leads to an improvement in left ventricular systolic function and quality of life in heart failure patients," Singh said in a statement. "Hence, yoga therapy may improve physical well-being and left ventricular function among heart failure patients on guideline-directed optimal medical therapy."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted October 2023
Read this next
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
Self-Administered Gerocognitive Exam Improves Detection of Cognitive Issues in Primary Care
TUESDAY, July 2, 2024 -- A self-administered gerocognitive examination (SAGE) is easily incorporated into primary care provider (PCP) visits, and its use significantly increases...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.